Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052584 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Silvia Bua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Carbonic Anhydrases, Tuberculosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Universities and Research, Research Institute of the University of Bucharest, Italian Ministry of University and Research.
Abstract (Originalsprache)
2H-Benzo[e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide (BTD) based carbonic anhydrase (CA) inhibitors are here explored as new anti-mycobacterial agents. The chemical features of BTD derivatives meet the criteria for a potent inhibition of β-class CA isozymes. BTD derivatives show chemical features meeting the criteria for a potent inhibition of β-class CA isozymes. Specifically, three β-CAs (MtCA1, MtCA2, and MtCA3) were identified in Mycobacterium tuberculosis and their inhibition was shown to exert an antitubercular action. BTDs derivatives 2a-q effectively inhibited the mycobacterial CAs, especially MtCA2 and MtCA3, with Ki values up to a low nanomolar range (MtCA3, Ki = 15.1–2250 nM; MtCA2, Ki = 38.1–4480 nM) and with a significant selectivity ratio over the off-target human CAs I and II. A computational study was conducted to elucidate the compound structure-activity relationship. Importantly, the most potent MtCA inhibitors demonstrated efficacy in inhibiting the growth of M. tuberculosis strains resistant to both rifampicin and isoniazid—standard reference drugs for Tuberculosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania.
- Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
- Faculty of Biology, University of Bucharest, Splaiul Independenței 91-95, 050095 Bucharest, Romania.
- St. Stephen's Pneumoftiziology Hospital, Șoseaua Ștefan cel Mare 11, 020122 Bucharest, Romania.
ORCID-Profile: Alessandro Bonardi, Georgiana Ramona Mük, Alessio Nocentini, Paola Gratteri, Claudiu T Supuran
Förderung
- Ministry of Education, Universities and Research
- Research Institute of the University of Bucharest
- Italian Ministry of University and Research
Zitieren
APA
Bua, S., Bonardi, A., Mük, G. R., Nocentini, A., Gratteri, P., & Supuran, C. T. (2024). Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052584
Vancouver
Bua S, Bonardi A, Mük GR, Nocentini A, Gratteri P, Supuran CT. Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052584
BibTeX
@article{Bua2024,
author = {Bua, Silvia and Bonardi, Alessandro and Mük, Georgiana Ramona and Nocentini, Alessio and Gratteri, Paola and Supuran, Claudiu T},
title = {Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052584}
}
EUVIMED